PRKACA and adrenal gland hyperfunction: PRKACA mediates PKA activation, which triggers steroidogenesis, and is involved in adrenocortical pathologies with ACTH-independent hypercortisolism, such as adrenocortical adenomas, carcinomas, or bilateral adrenocortical hyperplasias (40).